Raltegravir in treatment naïve patients
<p>Abstract</p> <p>Raltegravir is the first integrase inhibitor approved for the treatment of HIV infection based on the superior efficacy it showed compared to optimized backbone therapy alone in patients harboring multidrug resistant viruses. Studies on naïve patients showed comp...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2009-11-01
|
| Series: | European Journal of Medical Research |
| Online Access: | http://www.eurjmedres.com/content/14/S3/22 |